{
  "main_header": {
    "sid": 734514,
    "name": "Dr Reddy's Labs",
    "stock_name": "Dr Reddy's Labs",
    "full_name": "Dr Reddys Laboratories Ltd",
    "name_url": "stocks-analysis/dr-reddy-s-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,279.30",
    "chg": 5.8,
    "chgp": "0.46%",
    "dir": 1,
    "prev_price": "1,273.50",
    "mcapval": "106,236.00 Cr",
    "mcap": "Large Cap",
    "scripcode": "500124",
    "symbol": "DRREDDY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE089A01031",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "10.8 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-reddy-s-labs-734514-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-3757172",
        "imagepath": "",
        "date": "2025-12-12 09:21:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the elite group of companies that represent the Indian equity market’s broad performance. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, thereby embedding the stock deeply within passive investment strategies.</p>\n                <p>The company’s market capitalisation stands at ₹1,06,244 crores, categorising it firmly as a large-cap entity. This scale supports its inclusion in the benchmark index, which is desig..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-amid-sector-challenges-3756091",
        "imagepath": "",
        "date": "2025-12-11 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation</strong></p>\n                <p>As a large-cap stock with a market capitalisation of approximately ₹1,04,662.65 crores, Dr Reddys Laboratories maintains a pivotal role within the Nifty 50, India's premier benchmark index. This membership not only enhances the stock's visibility among institutional investors but also ensures its inclusion in various index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. The company's presence in the index signals its relative stability and market influence within the Pharmaceuticals & Biotechnology sector.</p>\n                <p>Dr Reddys Laboratories' price-to-earnings (P/E) ratio stands at 18.07, notably below the sector average of 33.47. This differential suggests a ..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3754924",
        "imagepath": "",
        "date": "2025-12-10 09:20:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for large-cap companies operating in competitive sectors like Pharmaceuticals & Biotechnology.</p>\n                <p>Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,04,327.65 crores, stands as a heavyweight within its sector. Its presence i..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3753139",
        "imagepath": "",
        "date": "2025-12-09 09:20:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the top-tier companies that shape the Indian equity market’s performance. This membership not only enhances the stock’s visibility among institutional investors but also influences trading volumes and liquidity. The company’s market capitalisation stands at approximately ₹1,05,245.73 crores, categorising it firmly as a large-cap stock. This scale supports its inclusion in the benchmark index, which is designed to represent the broader market’s health and direction.</p>\n\n                <p>Index membership often attracts passive fund flows from exchange-traded funds (ETFs) and index funds tracking the Nifty 50, thereby impacting demand dynamic..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3750480",
        "imagepath": "",
        "date": "2025-12-08 09:20:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the most influential and liquid stocks in the Indian equity market. This membership not only enhances visibility among domestic and international investors but also ensures inclusion in numerous index-tracking funds and ETFs. The company’s market capitalisation of approximately ₹1,06,414.20 crores categorises it firmly as a large-cap stock, reinforcing its importance in portfolio construction and benchmark comparisons.</p>\n                <p>Within the Pharmaceuticals & Biotechnology sector, Dr Reddys Laboratories stands out with a price-to-earnings (P/E) ratio of 18.46, which is notably lower than the sector average P/E of 33.92. Th..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-3747993",
        "imagepath": "",
        "date": "2025-12-05 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company’s market capitalisation stands at approximately ₹1,06,798.13 crores, categorising it firmly as a large-cap stock. This status not only influences portfolio allocations by major fund managers but also impacts the stock’s trading volumes and volatility patterns.</p>\n                <p>Being part of the benchmark index means that Dr Reddys Laboratories is closely monitored by market participants, with its performance contributing materially to the overall index movement. This linkage often results in the stock reflecting broader m..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-market-signals-3745798",
        "imagepath": "",
        "date": "2025-12-04 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Dr Reddys Laboratories represents one of the largest and most liquid stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). The company’s market capitalisation, currently at approximately ₹1,06,877 crores, firmly places it within the large-cap category, reinforcing its role as a benchmark stock within the Pharmaceuticals & Biotechnology sector.</p>\n                <p>Being part of the Nifty 50 index means that Dr Reddys Laboratories is subject to the dynamics of index rebalancing and fund ..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-3743256",
        "imagepath": "",
        "date": "2025-12-03 09:20:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company’s market capitalisation, standing at approximately ₹1,07,090.24 crores, places it firmly within the large-cap category, reinforcing its importance in the benchmark index. This status not only influences trading volumes but also impacts the stock’s inclusion in various passive investment vehicles tracking the Nifty 50.</p>\n                <p>Being part of this premier index means that Dr Reddys Laboratories is subject to periodic reviews that assess its market capitalisation, liquidity, and sector representation. These reviews e..."
      },
      {
        "title": "Dr Reddys Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-reddys-laboratories-upgraded-to-hold-on-technical-and-valuation-improvements-3740646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrReddysLaborat_mojoScore_3740646.png",
        "date": "2025-12-02 08:43:07",
        "description": "Dr Reddys Laboratories has experienced a revision in its market evaluation, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This shift comes amid a backdrop of mixed quarterly results and evolving market dynamics within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 418,
    "sid": "734514",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-reddys-laboratories-734514"
  },
  "announcements": [
    {
      "details": "Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions for the period ended September 30, 2019.",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 22, 2019, titled \"Dr. Reddy's Laboratories announces launch of",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Dr. Reddy s Laboratories enters Nutrition Segment with Celevida in India.\".",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has declared <strong>800%</strong> dividend, ex-date: 10 Jul 25",
          "dt": "2025-07-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:5</strong> stock split, ex-date: 28 Oct 24",
          "dt": "2024-10-28",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 28 Aug 06",
          "dt": "2006-08-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-12 09:21:10

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the elite group of companies that represent the Indian equity market’s broad performance. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, thereby embedding the stock deeply within passive investment strategies.

The company’s market capitalisation stands at ₹1,06,244 crores, categorising it firmly as a large-cap entity. This scale supports its inclusion in the benchmark index, which is desig...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-11 09:20:51

Index Membership and Market Capitalisation

As a large-cap stock with a market capitalisation of approximately ₹1,04,662.65 crores, Dr Reddys Laboratories maintains a pivotal role within the Nifty 50, India's premier benchmark index. This membership not only enhances the stock's visibility among institutional investors but also ensures its inclusion in various index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. The company's presence in the index signals its relative stability and market influence within the Pharmaceuticals & Biotechnology sector.

Dr Reddys Laboratories' price-to-earnings (P/E) ratio stands at 18.07, notably below the sector average of 33.47. This differential suggests a ...

Read More

Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-10 09:20:48

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for large-cap companies operating in competitive sectors like Pharmaceuticals & Biotechnology.

Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,04,327.65 crores, stands as a heavyweight within its sector. Its presence i...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics

2025-12-09 09:20:46

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the top-tier companies that shape the Indian equity market’s performance. This membership not only enhances the stock’s visibility among institutional investors but also influences trading volumes and liquidity. The company’s market capitalisation stands at approximately ₹1,05,245.73 crores, categorising it firmly as a large-cap stock. This scale supports its inclusion in the benchmark index, which is designed to represent the broader market’s health and direction.

Index membership often attracts passive fund flows from exchange-traded funds (ETFs) and index funds tracking the Nifty 50, thereby impacting demand dynamic...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-08 09:20:54

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the most influential and liquid stocks in the Indian equity market. This membership not only enhances visibility among domestic and international investors but also ensures inclusion in numerous index-tracking funds and ETFs. The company’s market capitalisation of approximately ₹1,06,414.20 crores categorises it firmly as a large-cap stock, reinforcing its importance in portfolio construction and benchmark comparisons.

Within the Pharmaceuticals & Biotechnology sector, Dr Reddys Laboratories stands out with a price-to-earnings (P/E) ratio of 18.46, which is notably lower than the sector average P/E of 33.92. Th...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-05 09:20:51

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company’s market capitalisation stands at approximately ₹1,06,798.13 crores, categorising it firmly as a large-cap stock. This status not only influences portfolio allocations by major fund managers but also impacts the stock’s trading volumes and volatility patterns.

Being part of the benchmark index means that Dr Reddys Laboratories is closely monitored by market participants, with its performance contributing materially to the overall index movement. This linkage often results in the stock reflecting broader m...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-04 09:21:04

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Dr Reddys Laboratories represents one of the largest and most liquid stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). The company’s market capitalisation, currently at approximately ₹1,06,877 crores, firmly places it within the large-cap category, reinforcing its role as a benchmark stock within the Pharmaceuticals & Biotechnology sector.

Being part of the Nifty 50 index means that Dr Reddys Laboratories is subject to the dynamics of index rebalancing and fund ...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-03 09:20:52

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company’s market capitalisation, standing at approximately ₹1,07,090.24 crores, places it firmly within the large-cap category, reinforcing its importance in the benchmark index. This status not only influences trading volumes but also impacts the stock’s inclusion in various passive investment vehicles tracking the Nifty 50.

Being part of this premier index means that Dr Reddys Laboratories is subject to periodic reviews that assess its market capitalisation, liquidity, and sector representation. These reviews e...

Read More

Dr Reddys Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-02 08:43:07

Dr Reddys Laboratories has experienced a revision in its market evaluation, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This shift comes amid a backdrop of mixed quarterly results and evolving market dynamics within the Pharmaceuticals & Biotechnology sector.

Read More

View All News